The 2023 update of the EULAR recommendations for the management of systemic lupus erythematosus (SLE) recommend hydroxychloroquine (HCQ) for all patients with ...

2 янв. 2024 г. · The updated recommendations provide consensus guidance on the management of SLE, combining evidence and expert opinion.

The 2023 update of the EULAR recommendations attempted to provide the state-of-the-art regarding the current treatment of SLE.

13 окт. 2023 г. · The 2023 updates provide 5 overarching principles and 13 recommendations to guide physicians treating lupus around the world.

EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Annals of the Rheumatic Diseases Published Online First: 12 October 2023.

The 2023 EULAR update recommends that treatment for LN should be continued for at least 3 years [1]. The BLISS-LN trial followed patients for 104 weeks, while ...

16 янв. 2024 г. · An international task force has updated the EULAR recommendations for SLE management based on new evidence and emerging therapies.

7 нояб. 2023 г. · Conclusion1. The 2023 EULAR recommendations for the management of SLE provide comprehensive guidance to healthcare professionals worldwide.

EULAR recommendations in lupus1: According to EULAR, prior use of a conventional immunosuppressive drug should not be mandatory for initiating a biologic.

Find the most recent EULAR updates on Systemic Lupus Erythematosus (SLE) treatment. The 2023 recommendations highlight the use of SAPHNELO for disease ...